Mirza Mansoor Raza 4
4 · Acrivon Therapeutics, Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Mirza Mansoor Raza
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+225,000→ 225,000 totalExercise: $1.81Exp: 2035-09-30→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on November 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.